Aruna Bio.png
Aruna Bio Announces Oral Presentation on Treatment Opportunities of Lead Program, AB126 at the Exosome Based Therapeutic Development Summit and Applications of Exosomes BioProcess International Conference & Exhibition
August 15, 2023 08:00 ET | Aruna Bio
BOSTON and ATHENS, Ga., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today...
Aruna Bio.png
Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Receives Entrepreneur Distinction from The University System of Georgia Board of Regents
March 28, 2023 08:00 ET | Aruna Bio
BOSTON and ATHENS, Ga., March 28, 2023 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today...
Aruna Bio.png
Aruna Bio Announces Appointment of Mike Ryan to its Board of Directors
December 19, 2022 08:00 ET | Aruna Bio
BOSTON and ATHENS, Ga., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today...
Aruna Bio.png
Aruna Bio Announces Presentation on Neural Exosome Treatment Opportunities and Lead Program, AB126 at Exosome Based Therapeutic Development Summit
October 06, 2022 08:00 ET | Aruna Bio
-AB126 is an unmodified exosome derived from neural stem cell lines with the innate ability to cross the blood-brain-barrier- -Preclinical data demonstrate the potential therapeutic activity of AB126...
Aruna Bio.png
Aruna Bio Closes $10.8 Million Common Stock Financing
April 14, 2021 08:00 ET | Aruna Bio
ATHENS, Ga. and RESEARCH TRIANGLE PARK, N.C., April 14, 2021 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases,...
Aruna Bio.png
Aruna Bio to Present at the Jefferies 2020 Healthcare Conference
May 26, 2020 07:00 ET | Aruna Bio
ATHENS, Ga. and RESEARCH TRIANGLE PARK, N.C., May 26, 2020 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today...